The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome

Neurology

Volumn 69, Issue 8, 2007, Pages 790-798

  Garland, E M ^a,b   Raj, S R ^a   Black, B K ^a   Harris, P A ^a   Robertson, D ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; DOPA; DOPAMINE; NORADRENALIN; RENIN;

ADRENALIN BLOOD LEVEL; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; AUTONOMIC DYSFUNCTION; BODY POSTURE; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DOPAMINE BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; PHENOTYPE; PLASMA RENIN ACTIVITY; POSTURAL TACHYCARDIA SYNDROME; PRIORITY JOURNAL; REFERENCE DATABASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STANDING; SUPINE POSITION; SYMPATHETIC TONE;

ADOLESCENT; ADULT; ALDOSTERONE; AUTONOMIC NERVOUS SYSTEM DISEASES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CATECHOLAMINES; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PHENOTYPE; POSTURE; PROSPECTIVE STUDIES; RENIN; SYMPATHETIC NERVOUS SYSTEM; SYNCOPE; TACHYCARDIA; WATER-ELECTROLYTE BALANCE;

EID: 34548140117     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000267663.05398.40     Document Type: Article

References (36)

1. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993;43:132-137.
2. Jacob G, Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 1999;317:88-101.
3. Jordan J, Shannon J, Robertson D. The physiological conundrum of hyperadrenergic orthostatic intolerance. Chin J Physiol 1997;40:1-8.
4. Jacob G, Robertson D, Mosqueda-Garcia R, Ertl AC, Robertson RM, Biaggioni I. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 1997;103:128-133.
5. Fouad FM, Tadena-Thome L, Bravo EL, Tarazi RC. Idiopathic hypovolemia. Ann Intern Med 1986;104:298-303.
6. Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005;111:1574-1582.
7. Jacob G, Atkinson D, Jordan J, et al. Effects of standing on cerebrovascular resistance in patients with idiopathic orthostatic intolerance. Am J Med 1999;106:59-64.
8. Jordan J, Shannon JR, Black BK, Paranjape SY, Barwise J, Robertson D. Raised cerebrovascular resistance in idiopathic orthostatic intolerance: evidence for sympathetic vasoconstriction. Hypertension 1998;32:699-704.
9. Stewart JM, Montgomery LD. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2004;287:H1319-H1327.
10. Stewart JM, Medow MS, Montgomery LD, McLeod K. Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow. Am J Physiol Heart Circ Physiol 2004;286:H1216-H1222.
11. Stewart JM, Medow MS, Montgomery LD. Local vascular responses affecting blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2003;285:H2749-H2756.
12. Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome N Engl J Med 2000;343:1008-1014.
13. Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-549.
14. Furlan R, Jacob G, Snell M, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 1998;98:2154-2159.
15. Jacob G, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Relation of blood volume and blood pressure in orthostatic intolerance. Am J Med Sci 1998;315:95-100.
16. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 2003;305:800-811.
17. Ishimitsu T, Minami J, Nishikimi T, et al. Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects. Hypertens Res 1998;21:15-22.
18. Foo M, Denver AE, Coppack SW, Yudkin JS. Effect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects. Clin Sci (Lond) 1998;95:157-164.
19. Alvelos M, Ferreira A, Bettencourt P, et al. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail 2004;6:593-599.
20. Robertson D, Frolich JC, Carr RK, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978;298:181-186.
21. Robertson D, Wade D, Workman R, Woosley RL, Oates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981;67:1111-1117.
22. Smits P, Pieters G, Thien T. The role of epinephrine in the circulatory effects of coffee. Clin Pharmacol Ther 1986;40:431-437.
23. Debrah K, Haigh R, Sherwin R, Murphy J, Kerr D. Effect of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 1995;89:475-480.
24. Goldstein DS. Adrenaline and the inner world: An introduction to scientific integrative medicine. Baltimore, MD: The Johns Hopkins University Press, 2006.
25. Jacob G, Shannon JR, Black B, et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997;96:575-580.
26. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 1988;81:213-220.
27. Gabbett T, Gass G, Gass E, Morris N, Bennett G, Thalib L. Norepinephrine and epinephrine responses during orthostatic intolerance in healthy elderly men. Jpn J Physiol 2000;50:59-66.
28. Novak V, Novak P, Opfer-Gehrking TL, O'Brien PC, Low PA. Clinical and laboratory indices that enhance the diagnosis of postural tachycardia syndrome. Mayo Clin Proc 1998;73:1141-1150.
29. Garland EM, Winker R, Williams SM, et al. Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension 2005;46:1103-1110.
30. Winker R, Garland EM, Rudiger HW, et al. Influence of an insertion variant in the 5′UTR of the endothelin-1 gene on orthostatic intolerance. Am J Med Sci 2005;330:166-171.
31. Bonyhay I, Freeman R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation 2004;110:3193-3198.
32. Goldstein DS, Eldadah B, Holmes C, Pechnik S, Moak J, Sharabi Y. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation 2005;111:839-845.
33. Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 2005;111:2734-2740.
34. Weinshilboum R, Axelrod J. Serum dopamine-beta-hydroxylase activity. Circ Res 1971;28:307-315.
35. Zabetian CP, Anderson GM, Buxbaum SG, et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001;68:515-522.
36. Winker R, Barth A, Valic E, et al. Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. Int Arch Occup Environ Health 2005;78:171-177.